The themes Medtronic is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
Shares of revenue are estimates for three months ended July 31, 2026, not figures from a filing.
Heart rhythm and ablation devices
Pacemakers, defibrillators, heart-monitoring devices, and catheters used to treat or monitor irregular heart rhythms. Named products include Micra pacemakers, Reveal LINQ monitors, PulseSelect catheters, and the Affera mapping and ablation system.
Heart valve and vascular products
Evolut devices replace a narrowed aortic valve through a catheter procedure. Medtronic also sells surgical heart valves, stent grafts for aortic disease, coronary stents, and balloons used in blood-vessel procedures.
Spine and neurosurgery products
Spine implants treat conditions such as spinal deformity and damaged discs. StealthStation provides navigation during surgery, O-arm provides operating-room imaging, and Mazor systems guide robotic-assisted spine procedures.
Neurological stimulation and stroke devices
InterStim devices stimulate nerves to treat bladder and bowel conditions; Inceptiv and Percept devices provide spinal or brain stimulation for certain conditions. Pipeline devices treat some brain aneurysms, and Solitaire devices are used in procedures for certain strokes.
Surgical and endoscopy products
Endo GIA staplers and LigaSure instruments are used during surgery; Hugo assists surgeons in certain procedures. PillCam cameras are swallowed to capture images inside the digestive tract, and GI Genius helps examine colonoscopy images.
Patient monitoring and airway products
Nellcor monitors measure blood oxygen, McGRATH MAC devices help clinicians place breathing tubes, and Shiley tubes help maintain a patient’s airway.
Medtronic designs, makes, and sells medical devices and related services to healthcare systems, clinicians, and patients in more than 150 countries. Its products include implanted heart devices, surgical tools, spine implants, equipment for monitoring patients, and therapies that use electrical stimulation to treat certain conditions. Its Diabetes Business became a separately listed company, MiniMed, through an initial public offering in March 2026, but its sales were still included in Medtronic’s July 2026 quarterly results.
Built from Medtronic plc’s own filings with the U.S. Securities and Exchange Commission (SEC). Figures are as reported, with per-share history restated onto today’s share basis. This describes a business — it is not investment advice and not a recommendation to buy or sell anything.
$101.00-0.6%Nov 12 close
Next earnings: November 24, 2026 · before the open
Figures through July 31, 2026, from the 10-Q filed September 3, 2026
Medtronic makes medical devices and therapies used to treat heart, brain, spine, surgical, and other health conditions.
Grade A+
The band under the price shows the grade on each date, built only from filings that were public by then.
Showing 2 of 40 quarters of Medtronic plc’s grade history. The other 38 go back to December 2016.